Zacks Investment Management Castle Biosciences Inc Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $68,943 - $100,883	3,541 Added 8.33%	46,030 $1.05 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $768,201 - $1.27 Million	42,489 New	42,489 $1 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $864,533 - $1.43 Million	-14,673 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $639,742 - $1.07 Million	14,673 New	14,673 $985,000

206

26.4M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $729M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.